Viewing Study NCT01489618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-01-26 @ 10:23 AM
Study NCT ID: NCT01489618
Status: TERMINATED
Last Update Posted: 2016-02-24
First Post: 2011-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Common Variable Immunodeficiency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Common variable immunodeficiency View
None pneumococcal vaccine View
None prime boost View